Altimmune CEO Jerry Durso strengthens company foundation for liver disease mission

Altimmune CEO Jerry Durso strengthens company foundation for liver disease mission
Altimmune CEO strengthens foundation

Altimmune, led by CEO Jerry Durso, is focusing on strengthening the foundational operations of the organization to further its mission of advancing treatments for serious liver diseases.

In a recent communication, Durso emphasized the importance of a robust organizational structure to support ongoing and future initiatives in the healthcare sector. This focus highlights Altimmune's commitment to innovation in treatment solutions, ensuring that the company remains at the forefront of combating liver diseases.

For more insights into the strategic direction of the company and to watch the full video, visit Altimmune's website.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.